{
    "2019-06-30": [
        [
            {
                "time": "2023-10-18",
                "original_text": "Pfizer's About to Enter a Sales Slump -- Here's Why You Should Like the Stock Anyway",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "Sales Slump",
                        "Stock"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2023-10-18",
                "original_text": "Pfizer's About to Enter a Sales Slump -- Here's Why You Should Like the Stock Anyway",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "Sales Slump",
                        "Stock"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}